![](/img/cover-not-exists.png)
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years*
Klonoff, David C., Buse, John B., Nielsen, Loretta L., Guan, Xuesong, Bowlus, Christopher L., Holcombe, John H., Wintle, Matthew E., Maggs, David G.Volume:
24
Language:
english
Journal:
Current Medical Research and Opinion
DOI:
10.1185/030079908x253870
Date:
January, 2008
File:
PDF, 740 KB
english, 2008